We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Bionano Genomics Inc (BNGO) USD0.0001

Sell:$0.21 Buy:$0.21 Change: $0.006 (2.96%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$0.21
Buy:$0.21
Change: $0.006 (2.96%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$0.21
Buy:$0.21
Change: $0.006 (2.96%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Contact details

Address:
9640 TOWNE CENTRE DRIVE
9640 TOWNE CENTRE DRIVE
SAN DIEGO
92121
United States
Telephone:
+1 (858) 8887600
Website:
https://bionano.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
BNGO
ISIN:
US09075F3055
Market cap:
$20.64 million
Shares in issue:
101.99 million
Sector:
Life Sciences Tools & Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • R. Erik Holmlin
    President, Chief Executive Officer, Principal Financial Officer, Director
  • Mark Oldakowski
    Chief Operating Officer
  • Jonathan Dixon
    General Counsel, Secretary
  • Alka Chaubey
    Chief Medical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.